March 18, 2020 / 11:15 AM / 18 days ago

BRIEF-Imv Inc Launches Plans To Advance Clinical Development Of A Vaccine Candidate Against Covid-19

March 18 (Reuters) - IMV Inc:

* IMV INC. LAUNCHES PLANS TO ADVANCE CLINICAL DEVELOPMENT OF A VACCINE CANDIDATE AGAINST COVID-19

* IMV INC - INTENDS TO DEVELOP ITS VACCINE CANDIDATE DPX-COVID-19 IN COLLABORATION WITH LEAD INVESTIGATORS FOR PHASE 1 CLINICAL STUDY Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below